Poremski, S.: Towards the De Novo Synthesis of Pseudaminic Acid. Master, 61 pp., Freie Universität, Berlin (2013)

Wang, H.: Functionalization of Soft Colloidal Probes for Biosensing. Master, 55 pp., Freie Universität, Berlin (2013)

Zhukova, Y.: Synthesis of porous PEG-protein particles by hard templating with CaCO₃. Master, 75 pp., Freie Universität, Berlin (2013)

Zimmermann, S.: The murine C-type lectin receptor Mincle: Functional characterization, ligand specificity, and its role in inflammation. Master, 74 pp., Universität Potsdam, Potsdam (2013)

Löffler, F. F.; Viana, I. F. T.; Fischer, N.; Coêlho, D. F.; Santos, C.; Jr, A. P.; Araujo, C.; Leite, B.; Durães-Carvalho, R.; Magalhaes, T. et al.; Morais, C.; Cordeiro, M. T.; Lins, R.; Marques, E. T.A.; Jaenisch, T.: Identification of a Zika NS2B epitope for which absence of IgG response is associated with severe neurological symptoms and the design of a biomarker capable of discriminatory diagnostics between severe and Non4 severe clinical phenotypes. ChemRxiv: the Preprint Server for Chemistry, 14170439 (2021)

Nie, C.; Trimpert, J.; Moon, S.-Y.; Haag, R.; Gilmore, K.; Kaufer, B. B.; Seeberger, P. H.: In vitro efficacy of Artemisia extracts against SARS-CoV-2. bioRxiv, 2021.02.14.431122 (2021)

Dahlke, C.; Heidepriem, J.; Kobbe, R.; Santer, R.; Koch, T.; Fathi, A.; Ly, M. L.; Schmiedel, S.; Seeberger, P. H.; ID-UKE COVID-19 study group et al.; Addo, M. M.; Löffler, F. F.: Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series. medRxiv (2020)

Joswig, J.-O.; Anders, J.; Zhang, H.-X.; Rademacher, C.; Keller, B. G.: Molecular Mechanism of the pH-Dependent Calcium Affinity in Langerin. bioRxiv, 986851 (2020)

Chatterjee, S.; Moon, S.-Y.; Rowlands, A.; Chin, F.; Seeberger, P. H.; Merbouh, N.; Gilmore, K.: Click, Zoom, Explore: Interactive 3D (i-3D) Figures in Standard Manuscript PDFs. ChemRxiv (2019)

Varon Silva, D.: ECBS & ICBS 2015 Joint Meeting: Bringing Chemistry to Life (ChemBioChem: A European Journal of Chemical Biology, 17). (2016)

Aoki-Kinoshita, K. F.; Sawaki, H.; An, H. J.; Campbell, M.; Cao, Q.; Cummings, R.; Hsu, D. K.; Kato, M.; Kawasaki, T.; Khoo, K.-H. et al.; Kim, J.; Kolarich, D.; Li, X.; Liu, M.; Matsubara, M.; Okuda, S.; Packer, N. H.; Ranzinger, R.; Shen, H.; Shikanai, T.; Shinmachi, D.; Toukach, P.; Yamada, I.; Yamaguchi, Y.; Yang, P.; Ying, W.; Yoo, J. S.; Zhang, Y.; Zhang, Y.; Narimatsu, H.: The fifth ACGG-DB meeting report: towards an international glycan structure repository (Glycobiology, 23). (2013), 3 pp.

Seeberger, P. H.: How can vaccine design be modified by the use of synthetic sugars?, (2017)

Koksch, B.; Seeberger, P. H.: Peptide Engineering Meeting 8. Peptide science 112 (1), e24146 (2020)

Macauley, M. S.; Rademacher, C.; Mariño, K. V.: Addressing roles for glycans in immunology using chemical biology. Frontiers in Chemistry 8, 471 (2020)

Koksch, B.; Seeberger, P. H.: Editorial overview: synthetic biomolecules: biopolymers. Current Opinion in Chemical Biology 40, pp. A4 - A5 (2017)

Hicks, M. G.; Seeberger, P. H.; Seeberger, P. H.: The Beilstein Journal of Organic Chemistry and the changing face of scientific publishing. Beilstein Journal of Organic Chemistry 11, pp. 2242 - 2244 (2015)

Seeberger, P. H.; Werz, D. B.: Glycochemistry and glycobiology: a web themed issue. Chemical Communications 47 (45), p. 12259 - 12259 (2011)

Seeberger, P. H.: Controlling science. ACS Chemical Biology 5 (7), pp. 623 - 624 (2010)

Seeberger, P. H.: Preparation method of outer core octasaccharide of Helicobacter pylori lipopolysaccharide. (2019)

Yin, J.; Hu, J.; Seeberger, P. H.; Qin, C.: Chemical synthesis method of plesiomonas shighelloides serotype O51 O-antigen oligosaccharide. (2019)

Yin, J.; Hu, J.; Seeberger, P. H.; Ye, Z.: Integrated nano system for liver-targeting co-delivery of genes/drugs and preparation method. (2019)

Seeberger, P. H.: Pneumococcal polysaccharide-protein conjugate composition. WO2017220753 (2018)

Seeberger, P. H.: Stable hydrolysis-resistant synthetic Polyribosylribitolphosphate derivates as vaccines against Haemophilus influenzae type b. (2018)

Correia, C. A.; Gilmore, K.; McQuade, D. T.; Seeberger, P. H.: Process for the preparation of Efavirenz and devices suitable therefore. (2017)

Gilmore, K.; Seeberger, P. H.; Pieber, B.; Chatterjee, S.: Modular continuous flow device. (2017)

Hofmann, J.; Hahm, H. S.; Seeberger, P. H.; Pagel, K.: Method for determining carbohydrates structure. (2017)

Khan, N.; Emmadi, M.: Synthetic vaccines against Streptococcus pneumoniae serotype 2. (2017)

Seeberger, P. H.; Pereira, C. L.; Parameswarappa, S. G.; Calow, A. D. J.; Menova, P.; Baek, J. Y.: Improved preparation of vaccines against Streptococcus pneumoniae type 3. (2017)

Chakkumkal, A.; Lisboa, M.; Martin, C. E.; Pereira, C. L.; Seeberger, P. H.; Khan, N.: Vaccines against Streptococcus pneumoniae serotype 5. WO2016198170 (2016)

Seeberger, P. H.; Martin, C. E.; Bröcker, F.; Chakkumkal, A.: Antibodies for prevention and treatment of diseases caused by Clostridium difficile. (2016)

Seeberger, P. H.; Pereira, C. L.; Chakkumkal, A.; Geißner, A.: Vaccines against Streptococcus pneumoniae serotype 4. EP3230297 (2016)

Seeberger, P. H.; Pereira, C. L.; Chakkumkal, A.; Schumann, B.; Parameswarappa, S. G.; Hahm, H. S.; Govindan, S.: Synthetic vaccines against Streptococcus pneumoniae serotype 8. (2016)

Seeberger, P. H.; Pereira, C. L.; Xiao, G.; Khan, N.; Chakkumkal, A.: Vaccine against carbapenem-resistant klebsiella pneumoniae. EP3274358 (2016)

Kopetzki, D.; McQuade, D. T.; Seeberger, P. H.; Gilmore, K.: Method and apparatus for the synthesis of dihydroartemisinin and artemisinin derivatives. WO2015007693 (2015)

Seeberger, P. H.; Pereira, C. L.: Synthetic vaccines against Streptococcus pneumoniae. (2015)

Seeberger, P. H.; Pereira, C. L.; Chakkumkal, A.; Schumann, B.: Synthetic vaccines against Streptococcus pneumoniae type 1. (2015)

Azzouz, N.; Götze, S.; Seeberger, P. H.; Varón Silva, D.; Tsai, Y.-H.: Synthesis of diverse glycosylphosphatidylinositol glycans from toxoplasma gondii and their application as vaccines and diagnostics. (2014)

Azzouz, N.; Götze, S.; Seeberger, P. H.; Varón Silva, D.; Tsai, Y.-H.: Synthesis of diverse glycosylphosphatidylinositol glycans and glycolipids from toxoplasma gondii and their application as diagnostic markers and vaccines. (2014)

Seeberger, P. H.; Yang, Y.; Chakkumkal, A.; Reinhardt, A.: Total synthesis and immunological evaluation of saccharide moieties of the lipopolysaccharide from neisseria meningitidis. EP2766024 A1 (2014)

Seeberger, P. H.; Kopetzki, D.; Lévesque, F.: Method and device for the synthesis of Artemisinin. EP2751113 (2013)

Seeberger, P. H.; Martin, C. E.; Bröcker, F.; Chakkumkal, A.: Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools. EP2739636 (2013)

Seeberger, P. H.; Stallforth, P.; De Libero, G.; Cavallari, M.: Polysaccharide antigen-glycolipid conjugate vaccines. EP2827899 (2013)

Seeberger, P. H.; Stallforth, P.; Delibero, G.; Cavallari, M.: Carbohydrate-glycolipid conjugate vaccines. (2013)

Seeberger, P. H.; Yang, Y.; Chakkumkal, A.; Reinhardt, A.: Total synthesis of the core tetrasaccharide of the lipopolysaccharide from Neisseria meningitidis. (2013)

Rathwell, D. C. K.; Parameswarappa, S. G.; Govindan, S.; Chakkumkal, A.; Pereira, C. L.; Seeberger, P. H.: Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3. WO2015040140 (2012)

Seeberger, P. H.; Grützmacher, H.; Tauer, K.; Bräuer, J.; Laurino, P.: Ultra fast process for the preparation of polymer nanoparticles. US8921442 (2012)

Seeberger, P. H.; Grützmacher, H.; Tauer, K.; Bräuer, J.; Laurino, P.: Process for the modification of polymers, in particular polymer nanoparticles. WO2012052147 (2012)

Seeberger, P. H.; Laurino, P.; Kikkeri, R.; O'Brien, A. G.; Klein, J. C.; Götze, S.: Continuous flow processes for photoconjugation of high-molecular chemical entities. (2012)

Seeberger, P. H.; Oberli, M.; Hecht, M.-L.: Oligosaccharides and oligosaccharide-protein conjugates derived from clostridium difficile polysaccharide PS-II, methods of synthesis and uses thereof, in particular as a vaccine. EP2683401 (2012)

Seeberger, P. H.; Boonyarattanakalin, S.; Lepenies, B.: Chemical synthesis of phosphatidylinositol mannoside glycans from Mycobacterium tuberculosis. EP2414372 (2010)